Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

Organon Usa Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic and branded alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has twenty-three approved drugs.

Summary for Organon Usa Inc

US Patents:	0
Tradenames:	25
Ingredients:	21
NDAs:	23

Drugs and US Patents for Organon Usa Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Usa Inc	PAVULON	pancuronium bromide	INJECTABLE;INJECTION	017015-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	LIQUAEMIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	000552-011	Apr 11, 1986		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	ORGATRAX	hydroxyzine hydrochloride	INJECTABLE;INJECTION	087014-002	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	ARDUAN	pipecuronium bromide	INJECTABLE;INJECTION	019638-001	Jun 26, 1990		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	METHYLPREDNISOLONE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	087535-002	Jun 25, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	LIQUAEMIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-002	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Organon Usa Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	080997-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Organon Usa Inc

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Usa Inc	REMERON SOLTAB	mirtazapine	TABLET, ORALLY DISINTEGRATING;ORAL	021208-002	Jan 12, 2001	5,977,099	See Plans and Pricing
Organon Usa Inc	GANIRELIX ACETATE	ganirelix acetate	INJECTABLE;INJECTION	021057-001	Jul 29, 1999	6,653,286	See Plans and Pricing
Organon Usa Inc	CALDEROL	calcifediol	CAPSULE;ORAL	018312-002	Approved Prior to Jan 1, 1982	3,565,924	See Plans and Pricing
Organon Usa Inc	DESOGEN	desogestrel; ethinyl estradiol	TABLET;ORAL-28	020071-002	Dec 10, 1992	3,927,046	See Plans and Pricing
Organon Usa Inc	CALDEROL	calcifediol	CAPSULE;ORAL	018312-001	Approved Prior to Jan 1, 1982	3,565,924	See Plans and Pricing
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-001	Mar 17, 1994	4,894,369*PED	See Plans and Pricing
Organon Usa Inc	RAPLON	rapacuronium bromide	INJECTABLE;INJECTION	020984-002	Aug 18, 1999	5,418,226	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ORGANON USA INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Baxter

Merck

Express Scripts

Dow

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.